CWGCX
Price
$63.10
Change
+$0.23 (+0.37%)
Updated
Apr 2 closing price
Net Assets
122.78B
ERBIX
Price
$17.83
Change
+$0.13 (+0.73%)
Updated
Apr 2 closing price
Net Assets
681.3M
Ad is loading...

CWGCX vs ERBIX

Header iconCWGCX vs ERBIX Comparison
Open Charts CWGCX vs ERBIXBanner chart's image
American Funds Capital World Gr&Inc C
Price$63.10
Change+$0.23 (+0.37%)
VolumeN/A
Net Assets122.78B
Eaton Vance RBA Equity Strategy Fd Cl I
Price$17.83
Change+$0.13 (+0.73%)
VolumeN/A
Net Assets681.3M
CWGCX vs ERBIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CWGCX vs. ERBIX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a Buy and ERBIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 123B vs. ERBIX (681M). CWGCX pays higher dividends than ERBIX: CWGCX (0.93) vs ERBIX (0.87). CWGCX was incepted earlier than ERBIX: CWGCX (24 years) vs ERBIX (14 years). CWGCX (1.49) is less costly to investors than ERBIX (1.05). ERBIX is a more actively managed with annual turnover of: 35.00 vs. CWGCX (27.00). CWGCX has a lower initial minimum investment than ERBIX: CWGCX (250) vs ERBIX (1000000). ERBIX annual gain was more profitable for investors over the last year : 1.71 vs. CWGCX (-0.74). CWGCX return over 5 years is better than : 61.34 vs. ERBIX (34.73).
CWGCXERBIXCWGCX / ERBIX
Total Expense Ratio1.491.05142%
Annual Report Gross Expense Ratio1.491.05142%
Fund Existence24 years14 years-
Gain YTD0.333-2.706-12%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets123B681M18,062%
Annual Yield % from dividends0.930.87106%
Returns for 1 year-0.741.71-43%
Returns for 3 years10.18-3.42-298%
Returns for 5 years61.3434.73177%
Returns for 10 years38.0724.65154%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACTG3.360.16
+5.00%
Acacia Research Corp
BBLG0.830.03
+4.37%
Bone Biologics Corp
PARR14.540.28
+1.96%
Par Pacific Holdings
MMLP3.55-0.05
-1.39%
Martin Midstream Partners LP
CORT91.93-22.29
-19.51%
Corcept Therapeutics